Skip Navigation


NDT Advance Access originally published online on May 9, 2008
Nephrology Dialysis Transplantation 2008 23(8):2447-2450; doi:10.1093/ndt/gfn232
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/8/2447    most recent
gfn232v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tsukamoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsukamoto, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



End-stage renal disease (ESRD) and its treatment in Japan

Yusuke Tsukamoto

Division of Nephrology and Kidney Center, Shuwa General Hospital, Kasukabe-shi, Japan

Correspondence and offprint requests to: Yusuke Tsukamoto, Division of Nephrology and Kidney Center, Shuwa General Hospital, 1200 Yaharashinden, Kasukabe-shi, Japan. E-mail: tsukamoto@jinzou.net

Keywords: BMI; CKD; dialysis; end-stage renal disease; transplant

The first 150 words of the full text of this article appear below.

In Japan, mandatory urine testing to detect kidney diseases and diabetes has been carried out for industrial workers (since 1972), school children (since 1973) and citizens over 40 years of age (since 1982) [1]. Despite these efforts, the prevalence of dialysis patients in Japan reached 264 473 (2069.9 per million) by the end of 2006 [2]. The increase in prevalence is no more exponential than the increase seen uptil 1995, but it has not yet reached its plateau phase. Why is the prevalence of ESRD per population the highest in Japan compared to all other nations (USRDS database: http://www.usrds.org/)? Japan is also known for having very few kidney transplants compared to the prevalence of ESRD. Not only is the total number of transplants low, but living donation is also the predominant choice for kidney transplantation (939 out of 1136 in 2007), which strongly differs from the . . . [Full Text of this Article]



   Dialysis therapy in Japan
 


   Kidney transplant in Japan
 
Japanese nephrologists and CKD initiative

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?